HCA
IRMD icon

Harbor Capital Advisors’s iRadimed IRMD Stock Holding History

Harbor Capital Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6K Buy
65
+2
+3% +$200 ﹤0.01% 1082
2025
Q4 		$6K Sell
63
-1
-2% -$86 ﹤0.01% 1091
2025
Q3 		$5K Buy
64
+41
+178% +$2.73K ﹤0.01% 1163
2025
Q2 		$1K Buy
23
+22
+2,200% +$1.21K ﹤0.01% 1358
2025
Q1 		$0 Sell
1
-115
-99% -$6.46K ﹤0.01% 1471
2024
Q4 		$6K Sell
116
-2
-2% -$105 ﹤0.01% 1088
2024
Q3 		$6K Buy
+118
New +$5.44K ﹤0.01% 1093

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbor Capital Advisors's IRMD Position: Q1 2026 in Review

Harbor Capital Advisors increased its iRadimed (IRMD) stake by 3.2% in Q1 2026, buying an estimated $200 and bringing the position to 65 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Harbor Capital Advisors first reported a position in IRMD in Q3 2024 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Harbor Capital Advisors held 65 shares of iRadimed worth $6K as of Q1 2026.
  • Harbor Capital Advisors bought 2 iRadimed shares in Q1 2026, an estimated $200.
  • iRadimed made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #1082 holding.
  • Harbor Capital Advisors first reported a position in iRadimed in Q3 2024 and has held it in 7 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.